MoneyWorks4Me

Goldline Pharmaceutical informs about disclosure

30 Jul 2026 Evaluate
Goldline Pharmaceutical has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prashant Shrikrishna Karkare.

The above information is a part of company’s filings submitted to BSE.
Peers